Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Donnem

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Anticancer Research|November 17, 2012
In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histologyMarte Eilertsen, Ingvild Pettersen, Sigve Andersen, et al.
Anticancer Research|October 23, 2009
Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancerSamer Al-Saad, Tom Donnem, Khalid Al-Shibli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cellsTom Donnem, Samer Al-Saad, Khalid Al-Shibli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancerKhalid I Al-Shibli, Tom Donnem, Samer Al-Saad, et al.
Cancer|August 26, 2010
Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survivalTom Donnem, Sigve Andersen, Khalid Al-Shibli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2010
Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patientsSamer Al-Saad, Khalid Al-Shibli, Tom Donnem, et al.
Histopathology|September 3, 2009
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinomaKhalid Al-Shibli, Samer Al-Saad, Tom Donnem, et al.
Cancer|June 16, 2010
Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancerTom Donnem, Khalid Al-Shibli, Sigve Andersen, et al.
Clinical Lung Cancer|May 10, 2011
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor sizeTom Donnem, Sigve Andersen, Samer Al-Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2008
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cellsTom Donnem, Khalid Al-Shibli, Samer Al-Saad, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Anticancer Research|November 17, 2012
In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histologyMarte Eilertsen, Ingvild Pettersen, Sigve Andersen, et al.
Anticancer Research|October 23, 2009
Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancerSamer Al-Saad, Tom Donnem, Khalid Al-Shibli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cellsTom Donnem, Samer Al-Saad, Khalid Al-Shibli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancerKhalid I Al-Shibli, Tom Donnem, Samer Al-Saad, et al.
Cancer|August 26, 2010
Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survivalTom Donnem, Sigve Andersen, Khalid Al-Shibli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2010
Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patientsSamer Al-Saad, Khalid Al-Shibli, Tom Donnem, et al.
Histopathology|September 3, 2009
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinomaKhalid Al-Shibli, Samer Al-Saad, Tom Donnem, et al.
Cancer|June 16, 2010
Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancerTom Donnem, Khalid Al-Shibli, Sigve Andersen, et al.
Clinical Lung Cancer|May 10, 2011
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor sizeTom Donnem, Sigve Andersen, Samer Al-Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2008
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cellsTom Donnem, Khalid Al-Shibli, Samer Al-Saad, et al.
Pageof 10